Dasbach EJ - Search Results

1

Modeling the durability of ZOSTAVAX® vaccine efficacy in people ≥60 years of age.

Li X, Zhang JH, Betts RF, Morrison VA, Xu R, Itzler RF, Acosta CJ, Dasbach EJ, Pellissier JM, Johnson GR, Chan IS. Li X, et al. Among authors: dasbach ej. Vaccine. 2015 Mar 17;33(12):1499-505. doi: 10.1016/j.vaccine.2014.10.039. Epub 2014 Nov 6. Vaccine. 2015. PMID: 25444784

2

Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach.

Hayajneh WA, Daniels VJ, James CK, Kanıbir MN, Pilsbury M, Marks M, Goveia MG, Elbasha EH, Dasbach E, Acosta CJ. Hayajneh WA, et al. BMC Infect Dis. 2018 Mar 7;18(1):119. doi: 10.1186/s12879-018-3034-8. BMC Infect Dis. 2018. PMID: 29514609 Free PMC article.

3

Correction to: Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach.

Hayajneh WA, Daniels VJ, James CK, Kanıbir MN, Pilsbury M, Marks M, Goveia MG, Elbasha EH, Dasbach E, Acosta CJ. Hayajneh WA, et al. BMC Infect Dis. 2019 Oct 28;19(1):904. doi: 10.1186/s12879-019-4533-y. BMC Infect Dis. 2019. PMID: 31660877 Free PMC article.

4

Impact of vaccinating boys and men against HPV in the United States.

Elbasha EH, Dasbach EJ. Elbasha EH, et al. Among authors: dasbach ej. Vaccine. 2010 Oct 4;28(42):6858-67. doi: 10.1016/j.vaccine.2010.08.030. Epub 2010 Aug 14. Vaccine. 2010. PMID: 20713101

5

Planning for monitoring the introduction and effectiveness of new vaccines using real-word data and geospatial visualization: An example using rotavirus vaccines with potential application to SARS-CoV-2.

Mast TC, Heyman D, Dasbach E, Roberts C, Goveia MG, Finelli L. Mast TC, et al. Vaccine X. 2021 Apr;7:100084. doi: 10.1016/j.jvacx.2021.100084. Epub 2021 Jan 9. Vaccine X. 2021. PMID: 33521625 Free PMC article.

6

Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico: a transmission dynamic model-based evaluation.

Insinga RP, Dasbach EJ, Elbasha EH, Puig A, Reynales-Shigematsu LM. Insinga RP, et al. Among authors: dasbach ej. Vaccine. 2007 Dec 21;26(1):128-39. doi: 10.1016/j.vaccine.2007.10.056. Epub 2007 Nov 20. Vaccine. 2007. PMID: 18055075

7

Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: a systematic review of conclusions and assumptions.

Ogilvie I, Khoury AE, Cui Y, Dasbach E, Grabenstein JD, Goetghebeur M. Ogilvie I, et al. Vaccine. 2009 Aug 6;27(36):4891-904. doi: 10.1016/j.vaccine.2009.05.061. Epub 2009 Jun 9. Vaccine. 2009. PMID: 19520205 Review.

8

Age-based programs for vaccination against HPV.

Elbasha EH, Dasbach EJ, Insinga RP, Haupt RM, Barr E. Elbasha EH, et al. Among authors: dasbach ej. Value Health. 2009 Jul-Aug;12(5):697-707. doi: 10.1111/j.1524-4733.2009.00512.x. Value Health. 2009. PMID: 19490561 Free article.

9

The Cost-Effectiveness Analysis of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) for Females in Japan.

Yamabe K, Singhal PK, Abe M, Dasbach EJ, Elbasha EH. Yamabe K, et al. Among authors: dasbach ej. Value Health Reg Issues. 2013 May;2(1):92-97. doi: 10.1016/j.vhri.2013.02.001. Epub 2013 Mar 29. Value Health Reg Issues. 2013. PMID: 29702859 Free article.

10

Model for assessing human papillomavirus vaccination strategies.

Elbasha EH, Dasbach EJ, Insinga RP. Elbasha EH, et al. Among authors: dasbach ej. Emerg Infect Dis. 2007 Jan;13(1):28-41. doi: 10.3201/eid1301.060438. Emerg Infect Dis. 2007. PMID: 17370513 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters